These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24367274)

  • 1. Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.
    Atak ZK; Gianfelici V; Hulselmans G; De Keersmaecker K; Devasia AG; Geerdens E; Mentens N; Chiaretti S; Durinck K; Uyttebroeck A; Vandenberghe P; Wlodarska I; Cloos J; Foà R; Speleman F; Cools J; Aerts S
    PLoS Genet; 2013; 9(12):e1003997. PubMed ID: 24367274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
    Prodduturi N; Bhagwate A; Kocher JA; Sun Z
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indel detection from RNA-seq data: tool evaluation and strategies for accurate detection of actionable mutations.
    Sun Z; Bhagwate A; Prodduturi N; Yang P; Kocher JA
    Brief Bioinform; 2017 Nov; 18(6):973-983. PubMed ID: 27473065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
    Chen B; Jiang L; Zhong ML; Li JF; Li BS; Peng LJ; Dai YT; Cui BW; Yan TQ; Zhang WN; Weng XQ; Xie YY; Lu J; Ren RB; Chen SN; Hu JD; Wu DP; Chen Z; Tang JY; Huang JY; Mi JQ; Chen SJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):373-378. PubMed ID: 29279377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
    Li Z; Abraham BJ; Berezovskaya A; Farah N; Liu Y; Leon T; Fielding A; Tan SH; Sanda T; Weintraub AS; Li B; Shen S; Zhang J; Mansour MR; Young RA; Look AT
    Leukemia; 2017 Oct; 31(10):2057-2064. PubMed ID: 28260788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL.
    Norvilas R; Batiuskaite R; Dirse V; Semaskeviciene R; Gineikiene E; Stoskus M; Vaitkeviciene G; Rascon J; Griskevicius L
    Leuk Res; 2022 May; 116():106825. PubMed ID: 35339799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
    Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
    BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Atak ZK; Li N; Vicente C; Patchett S; Girardi T; Gianfelici V; Geerdens E; Clappier E; Porcu M; Lahortiga I; Lucà R; Yan J; Hulselmans G; Vranckx H; Vandepoel R; Sweron B; Jacobs K; Mentens N; Wlodarska I; Cauwelier B; Cloos J; Soulier J; Uyttebroeck A; Bagni C; Hassan BA; Vandenberghe P; Johnson AW; Aerts S; Cools J
    Nat Genet; 2013 Feb; 45(2):186-90. PubMed ID: 23263491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High accuracy mutation detection in leukemia on a selected panel of cancer genes.
    Kalender Atak Z; De Keersmaecker K; Gianfelici V; Geerdens E; Vandepoel R; Pauwels D; Porcu M; Lahortiga I; Brys V; Dirks WG; Quentmeier H; Cloos J; Cuppens H; Uyttebroeck A; Vandenberghe P; Cools J; Aerts S
    PLoS One; 2012; 7(6):e38463. PubMed ID: 22675565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
    López-Nieva P; Fernández-Navarro P; Graña-Castro O; Andrés-León E; Santos J; Villa-Morales M; Cobos-Fernández MÁ; González-Sánchez L; Malumbres M; Salazar-Roa M; Fernández-Piqueras J
    Sci Rep; 2019 Mar; 9(1):5179. PubMed ID: 30914738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
    Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
    Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
    Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
    Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.
    Homminga I; Pieters R; Langerak AW; de Rooi JJ; Stubbs A; Verstegen M; Vuerhard M; Buijs-Gladdines J; Kooi C; Klous P; van Vlierberghe P; Ferrando AA; Cayuela JM; Verhaaf B; Beverloo HB; Horstmann M; de Haas V; Wiekmeijer AS; Pike-Overzet K; Staal FJ; de Laat W; Soulier J; Sigaux F; Meijerink JP
    Cancer Cell; 2011 Apr; 19(4):484-97. PubMed ID: 21481790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.